---
edited: 2024-03-02
tags:
---
### Staging
T-staging

| T   | [[Endoscopic ultrasound]] findings                                   | Surgical approach                                                                                                                                                                                                                                                                                 | Additional treatments                                                |
| --- | -------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | -------------------------------------------------------------------- |
| Tis | Intraepithelial tumor, lamina propria not affected<br>               | **Options**: [[Gastrectomy]] or endoscopic procedures<br>- Endoscopic mucosal resection<br>- Endoscopic submucosal dissection<br>- Indication: well-differentiated, nonulcerated tumor ≤ 2 cm limited to the mucosa<br>- Technique: tumor resection or dissection completely through an endoscope | [[Anti H. pylori therapy]]                                           |
| T1  | T1a: lamina propria<br>T1b: submucosa                                | surgical resection (i.e. [[Gastrectomy]]) or endoscopic procedures                                                                                                                                                                                                                                | [[Anti H. pylori therapy]]                                           |
| T2  | Muscularis propria                                                   | [[Gastrectomy]] + LN dissection (d2)<br>- Proximal lesion: Total Gastrectomy<br>- Distal lesion: Subtotal Gastrectomy                                                                                                                                                                             | [[Neoadjuvant therapy]] and [[Adjuvant therapy]] or [[Radiotherapy]] |
| T3  | Subserosal tissue                                                    | [[Gastrectomy]] + D2 LN dissection                                                                                                                                                                                                                                                                | ''''                                                                 |
| T4  | T4a: Serosa (visceral peritoneum)<br>T4b: Adjacent organs/structures | Provide [[Palliative surgery]]                                                                                                                                                                                                                                                                    | ''''                                                                 |
### N-staging

| N   | CECT scans                                                                           |
| --- | ------------------------------------------------------------------------------------ |
| N1  | 1–2 regional lymph node metastases                                                   |
| N2  | 3–6 regional lymph node metastases                                                   |
| N3  | N3a: 7–15 regional lymph node metastases<br>N3b: ≥ 16 regional lymph node metastases |
### M-staging

| M   | CECT/PET-scans |                                 | Further investigations                                                                     | Treatment                                              |
| --- | -------------- | ------------------------------- | ------------------------------------------------------------------------------------------ | ------------------------------------------------------ |
| Mo  | No metastasis  | Pontentially resectable disease | [[Diagnostic laparoscopy]] to look whether [[peritoneal carcinomatosis]] is present or not | Depends upon tumor depth, mentioned above in T-staging |
| M1  | Metastasis     | Unresectable                    |                                                                                            | [[Palliative surgery]]                                 |
### Cancer surgeries

| Cancer       | Management                                                                         |
| ------------ | ---------------------------------------------------------------------------------- |
| Resectable   | [[Gastrectomy]]+ Chemotherapy (Adjuvant/Neoadjuvant) + Radiation (mentioned above) |
| Unresectable | [[Palliative surgery]]                                                             |
### Chemotherapy regimens

|                      | **Indications for **                                                                                                                            | **Typical Regimens**                                                                                                                                                                                           |
| -------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| **Chemotherapy**     | - Perioperative treatment (neoadjuvant and adjuvant therapy) of resectable disease<br>- Primary treatment of metastatic or unresectable disease | - Fit patients: double- or triple-agent therapy consisting of a platinum-based agent PLUS fluoropyrimidine, ± taxane<br> - Frail patients: single-agent therapy with a fluoropyrimidine, irinotecan, or taxane |
| **Radiotherapy**     | - Chemoradiation can be used as adjuvant therapy or as primary treatment for unresectable disease                                               | - Consider radiotherapy for palliative symptom control.                                                                                                                                                        |
| **Targeted Therapy** | VEGF expression                                                                                                                                 | Ramucirumab, Bevacizumab                                                                                                                                                                                       |
|                      | MSI and/or PD-L1 overexpression                                                                                                                 | [[Cancer immunotherapy]]                                                                                                                                                                                       |
|                      | HER2-positive metastatic disease.                                                                                                               | Trastuzumab                                                                                                                                                                                                    |


---
